Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A single-cell atlas of RNA alternative splicing in the glioma-immune ecosystem. | Genome Biol | 2025 | 41387900 | PubTator, text mining | PubMed |
| High Diagnostic Yield of Genetic Screening in Autosomal Dominant Steroid-Resistant Nephrotic Syndrome: Predominance of INF2 and TRPC6 and Identification of a Novel Gene. | Nephrology (Carlton) | 2025 | 41326026 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of Aqueous Humor, Anterior Lens Capsules, and Crystalline Lenses in Different Human Cataract Subtypes Versus Healthy Controls. | Proteomes | 2025 | 41283652 | PubTator, text mining | PubMed |
| Prognostic Significance of Actinin-4 Protein Expression and Gene Amplification in Endometrial Carcinoma. | J Obstet Gynaecol Res | 2025 | 41218617 | PubTator, text mining | PubMed |
| A Constant Pressure-Driven Podocyte-on-Chip Model for Studying Hypertension-Induced Podocytopathy Pathomechanism and Drug Screening. | Micromachines (Basel) | 2025 | 41156344 | PubTator, text mining | PubMed |
| Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132500 | PubTator, text mining | PubMed |
| Reproducibility and transparency: why following MISEV guidelines is beneficial for the studies on EVs and brain barriers. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132499 | PubTator, text mining | PubMed |
| ACTN4 Gene Amplification and Actinin-4 Protein Expression for Osimertinib Efficacy in EGFR-Mutant NSCLC. | Cancer Sci | 2025 | 41074261 | PubTator, text mining | PubMed |
| Circulating Cardiovascular Proteomic Associations With Genetics and Disease. | Circ Genom Precis Med | 2025 | 41054850 | PubTator, text mining | PubMed |
| Early use of renin-angiotensin-aldosterone system inhibitors and stable renal function in familial focal segmental glomerulosclerosis with ACTN4 mutation: a case report and literature review. | BMC Nephrol | 2025 | 41013435 | PubTator, text mining | PubMed |
| Early host-parasite interaction models reveal a key role for fibrinolysis in Fasciola hepatica intestinal migration. | Parasit Vectors | 2025 | 40993705 | PubTator, text mining | PubMed |
| Dysregulated Anaerobic Glycolysis in Podocytes is Relevant to the Progression of Focal Segmental Glomerulosclerosis. | Kidney Int Rep | 2025 | 40980659 | PubTator, text mining | PubMed |
| Super-enhancer-associated LINC00963 promotes metastasis of gastric cancer through epithelial-mesenchymal transition. | PLoS One | 2025 | 40966274 | PubTator, text mining | PubMed |
| Retraction Note: TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9. | Sci Rep | 2025 | 40962880 | PubTator, text mining | PubMed |
| A pediatric-onset case of chronic kidney disease caused by a novel sporadic ACTN4 variant and literature review. | Turk J Pediatr | 2025 | 40925038 | PubTator, text mining | PubMed |
| Novel WT1 and ACTN4 co-mutations in a patient with Denys-Drash syndrome and an atypical, potentially attenuated presentation of nephropathy: a case report. | BMC Nephrol | 2025 | 40890712 | PubTator, text mining | PubMed |
| Maspin/SerpinB5 is a cytoskeleton-binding protein that regulates epithelial cell shape. | Commun Biol | 2025 | 40846899 | PubTator, text mining | PubMed |
| Unraveling the role of the WIPF1/ACTN4 complex in podosome formation of human placental EVTs: Insights into recurrent spontaneous abortion. | Genes Dis | 2025 | 40821124 | PubTator, text mining | PubMed |
| A nomogram integrating mutation signatures and clinical features for prognostic stratification in bladder cancer. | Discov Oncol | 2025 | 40815405 | PubTator, text mining | PubMed |
| Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy. | J Inflamm Res | 2025 | 40735269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=3